USD 30.23 billion growth expected in Non-Small Cell Lung Cancer Drugs Market | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio

NEW YORK, April 20, 2022 /PRNewswire/ -- The global non-small cell lung cancer drugs market size is expected to increase by USD 30.23 billion between 2021 and 2026, expanding at a CAGR of 17.1% during the forecast period. The report identifies AbbVie Inc., Amgen Inc., Astellas Pharma...

Click to view original post